%PDF-1.4
%
35 0 obj
<>
endobj
32 0 obj
<>
endobj
91 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-09T12:55:15Z
2024-03-28T11:33:54-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T11:33:54-07:00
application/pdf
Heather
2001-1021.august
uuid:8d812afb-1dd2-11b2-0a00-9408277d8900
uuid:8d812afe-1dd2-11b2-0a00-d30000000000
endstream
endobj
21 0 obj
<>
endobj
22 0 obj
<>
endobj
36 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
105 0 obj
[109 0 R]
endobj
106 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0249 Tw 8 0 0 8 74.4 714.5293 Tm
[(cooperative, Seattle, )17.7 (W)79.8 (ashington, 1987-1989. )54.8 (Arthritis Rheum)]TJ
0 Tw 0 -1.25 TD
(1991;34:1502-7.)Tj
0.02499 Tw -1.675 -1.25 Td
[(6.)-875 (Hochber)17.8 (g MC. Changes in the incidence and prevalence of)]TJ
1.675 -1.25 Td
[(rheumatoid arthritis in England and )17.8 (W)79.8 (ales, 1970-1982. Semin)]TJ
T*
(Arthritis Rheum 1990;19:294-302.)Tj
-1.675 -1.25 Td
[(7.)-875 (Silman )54.9 (AJ. Has the incidence of rheumatoid arthritis declined in the)]TJ
1.675 -1.25 Td
(United Kingdom? Br J Rheumatol 1988;27:77-9.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(8.)-875.1 (Jacobsson L)91.7 (T)73.9 (, Hanson RL, Knowler )17.7 (WC, et al. Decreasing)]TJ
0 Tc 1.675 -1.25 Td
(incidence and prevalence of rheumatoid arthritis in Pima Indians)Tj
-0.00011 Tc T*
[(over a twenty-five-year period. )54.8 (Arthritis Rheum 1994;37:1)36.7 (158-65.)]TJ
-1.675 -1.25 Td
[(9.)-875.1 (Doran M, Pond G, Crowson C, O\222Fallon )17.7 (W)91.7 (, Gabriel S. )17.7 (T)34.8 (rends in)]TJ
0 Tc 1.675 -1.25 Td
[(the incidence and mortality in rheumatoid arthritis in Rochester)39.8 (,)]TJ
T*
[(Minnesota, over a 40-year period. )54.9 (Arthritis Rheum 2002;46:625-31.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(10.)-875.1 (Petursdottir )17.7 (V)129 (, Johansson H, Nordbor)17.7 (g E, Nordbor)17.7 (g C. )17.7 (The)]TJ
0 Tc 2.175 -1.25 Td
(epidemiology of biopsy-positive giant cell arteritis: special)Tj
T*
(reference to cyclic fluctuations. Rheumatology 1999;38:1208-12.)Tj
-2.1381 -1.25 Td
[(1)36.9 (1.)-875 (Gran JT)74 (, Myklebust G. )17.7 (The incidence of polymyalgia rheumatica)]TJ
2.1381 -1.25 Td
[(and temporal arteritis in the county of )54.8 (Aust )54.8 (Agder)39.8 (, south Norway: a)]TJ
T*
(prospective study 1987-94. J Rheumatol 1997;24:1739-43.)Tj
-2.175 -1.25 Td
[(12.)-875 (Boesen P)110.8 (,)0.1 ( Sorensen SF)79.8 (. Giant cell arteritis, temporal arteritis, and)]TJ
2.175 -1.25 Td
[(polymyalgia rheumatica in a Danish county)64.9 (. )54.9 (A)-219.8 (prospective)]TJ
T*
[(investigation, 1982-1985. )54.9 (Arthritis Rheum 1987;30:294-9.)]TJ
30.825 26.25 Td
[(13.)-875 (Schaufelber)17.8 (ger C, Bengtsson BA, )54.8 (Andersson R. Epidemiology and)]TJ
2.175 -1.25 Td
(mortality in 220 patients with polymyalgia rheumatica. Br J)Tj
T*
(Rheumatol 1995;34:261-4.)Tj
-2.175 -1.25 Td
[(14.)-875 (Franzen P)110.8 (, Sutinen S, von Knorring J. Giant cell arteritis and)]TJ
2.175 -1.25 Td
(polymyalgia rheumatica in a region of Finland: an epidemiologic,)Tj
T*
[(clinical and pathologic study)64.9 (, 1984-1988. J Rheumatol)]TJ
0 Tw T*
(1992;19:273-6.)Tj
0.02499 Tw -2.175 -1.25 Td
[(15.)-875 (Salvarani C, Macchioni P)110.8 (, Zizzi F)79.8 (, et al. Epidemiologic and)]TJ
2.175 -1.25 Td
(immunogenetic aspects of polymyalgia rheumatica and giant cell)Tj
T*
[(arteritis in northern Italy)64.9 (. )54.8 (Arthritis Rheum 1991;34:351-6.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(16.)-875.1 (Gonzalez-Gay MA, Garcia-Porrua C, )17.7 (V)111 (azquez-Caruncho M,)]TJ
0 Tc 2.175 -1.25 Td
[(Dababneh )54.8 (A, Hajeer )54.8 (A, Ollier )17.7 (WE. )17.7 (The spectrum of polymyalgia)]TJ
T*
(rheumatica in northwestern Spain: incidence and analysis of)Tj
T*
[(variables associated with relapse in a 10 year study)64.9 (. J Rheumatol)]TJ
0 Tw T*
(1999;26:1326-32.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (Jonasson F)79.7 (,)-0.1 ( Cullen JF)79.7 (, Elton RA. )17.7 (T)69.7 (emporal arteritis. )54.8 (A)-219.9 (14-year)]TJ
0 Tc 2.175 -1.25 Td
[(epidemiological, clinical and prognostic study)64.9 (. Scot Med J)]TJ
0 Tw T*
[(1979;24:1)36.9 (1)36.9 (1-7.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(18.)-875.1 (Sorensen S, Lorenzen I. Giant-cell arteritis, temporal arteritis and)]TJ
0 Tc 2.175 -1.25 Td
[(polymyalgia rheumatica. )54.9 (A)-219.8 (retrospective study of 63 patients. )54.9 (Acta)]TJ
T*
(Med Scand 1977;201:207-13.)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT1 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Doran, et al: PMR incidence tr)36.9 (ends)]TJ
0 Tw 60.9375 -0.0313 Td
(1697)Tj
ET
0 0 0 0 scn
/GS0 gs
103.36 58.05 407.5 -10.84 re
f*
0.5 w
103.36 58.05 407.5 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
82 0 obj
<>
endobj
96 0 obj
<>
endobj
45 0 obj
<>
endobj
39 0 obj
<>
endobj
40 0 obj
<>
endobj
77 0 obj
<>stream
HVpTι&B K"&Yt@